Tokio Marine Asset Management Co. Ltd. Increases Holdings in Humana Inc. (NYSE:HUM)

Tokio Marine Asset Management Co. Ltd. increased its position in Humana Inc. (NYSE:HUM) by 13.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,249 shares of the insurance provider’s stock after acquiring an additional 386 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Humana were worth $1,029,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV raised its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. raised its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. bought a new position in shares of Humana during the third quarter valued at approximately $29,000. Ashton Thomas Securities LLC purchased a new stake in shares of Humana during the third quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP increased its position in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 2.6 %

HUM stock opened at $275.67 on Friday. The business’s 50 day simple moving average is $283.00 and its 200 day simple moving average is $331.80. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $33.19 billion, a PE ratio of 24.42, a PEG ratio of 2.29 and a beta of 0.52. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, research analysts anticipate that Humana Inc. will post 15.83 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.28%. Humana’s payout ratio is currently 31.36%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HUM. Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and upped their price target for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and reduced their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Stephens restated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Finally, TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Humana has an average rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.